Menta Capital’s NuVasive, Inc. NUVA Stock Holding History

Menta Capital’s Portfolio NUVA Stock Details NUVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-5,500	Closed	-$253K	–	793
2015 Q1	$253K	Buy	+5,500	New	+$256K	0.03%	591

Other funds holding NUVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Menta Capital's NUVA Position: Q2 2015 in Review

Menta Capital sold out of NuVasive, Inc. (NUVA) in Q2 2015, closing a stake of 5,500 shares — an estimated $253K sold.

Menta Capital first reported a position in NUVA in Q1 2015 and held it in 1 quarter. The position peaked at $253K in Q1 2015. 221 funds tracked by Wall St. Rank hold NUVA as of Q2 2015.

Menta Capital reported no remaining NuVasive, Inc. position as of Q2 2015 after selling out during the quarter.
Menta Capital sold 5,500 NuVasive, Inc. shares in Q2 2015, an estimated $253K.
Menta Capital first reported a position in NuVasive, Inc. in Q1 2015 and held it in 1 quarter.
Menta Capital's NuVasive, Inc. position peaked at $253K in Q1 2015.
221 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q2 2015.

Based on Menta Capital's 13F filing for Q2 2015, filed 11 Aug 2015.